- Home
- PLBC vs AQST Comparison
PLBC vs AQST Comparison
Compare PLBC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLBC | AQST |
|---|---|---|
| Founded | 1980 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.6M | 809.3M |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PLBC | AQST |
|---|---|---|
| Price | $47.00 | $5.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $55.00 | $8.83 |
| AVG Volume (30 Days) | 21.5K | ★ 2.3M |
| Earning Date | 01-14-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | ★ $89,868,000.00 | $43,397,000.00 |
| Revenue This Year | $21.11 | N/A |
| Revenue Next Year | $16.11 | $52.69 |
| P/E Ratio | $10.92 | ★ N/A |
| Revenue Growth | ★ 12.51 | N/A |
| 52 Week Low | $38.71 | $2.12 |
| 52 Week High | $49.47 | $7.55 |
Technical Indicators
Market Signals| Indicator | PLBC | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 44.66 |
| Support Level | $43.50 | $5.61 |
| Resistance Level | $47.03 | $6.44 |
| Average True Range (ATR) | 0.79 | 0.31 |
| MACD | 0.20 | -0.05 |
| Stochastic Oscillator | 77.94 | 16.00 |
Price Performance
Historical ComparisonAbout PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.